Bausch Health Cos Cash on Hand 2010-2024 | BHC

Bausch Health Cos cash on hand from 2010 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Bausch Health Cos Annual Cash on Hand
(Millions of US $)
2023 $962
2022 $591
2021 $2,119
2020 $1,816
2019 $3,244
2018 $723
2017 $797
2016 $542
2015 $597
2014 $323
2013 $600
2012 $916
2011 $170
2010 $400
2009 $124
Bausch Health Cos Quarterly Cash on Hand
(Millions of US $)
2024-09-30 $750
2024-06-30 $623
2024-03-31 $755
2023-12-31 $962
2023-09-30 $780
2023-06-30 $588
2023-03-31 $531
2022-12-31 $591
2022-09-30 $497
2022-06-30 $1,879
2022-03-31 $2,460
2021-12-31 $2,119
2021-09-30 $1,904
2021-06-30 $1,856
2021-03-31 $1,893
2020-12-31 $1,816
2020-09-30 $1,988
2020-06-30 $1,907
2020-03-31 $1,923
2019-12-31 $3,244
2019-09-30 $827
2019-06-30 $880
2019-03-31 $784
2018-12-31 $723
2018-09-30 $973
2018-06-30 $838
2018-03-31 $909
2017-12-31 $797
2017-09-30 $1,892
2017-06-30 $2,025
2017-03-31 $1,210
2016-12-31 $542
2016-09-30 $659
2016-06-30 $852
2016-03-31 $1,310
2015-12-31 $597
2015-09-30 $1,420
2015-06-30 $958
2015-03-31 $12,219
2014-12-31 $323
2014-09-30 $809
2014-06-30 $531
2014-03-31 $576
2013-12-31 $600
2013-09-30 $596
2013-06-30 $2,539
2013-03-31 $414
2012-12-31 $916
2012-09-30 $258
2012-06-30 $395
2012-03-31 $332
2011-12-31 $170
2011-09-30 $258
2011-06-30 $242
2011-03-31 $406
2010-12-31 $400
2010-09-30 $598
2010-06-30 $183
2010-03-31 $111
2009-12-31 $124
2009-09-30 $61
2009-06-30 $64
2009-03-31 $307
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $3.012B $8.757B
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.044B 6.25
Dr Reddy's Laboratories (RDY) India $11.978B 22.92
BridgeBio Pharma (BBIO) United States $4.260B 0.00
Amphastar Pharmaceuticals (AMPH) United States $2.097B 12.61
Supernus Pharmaceuticals (SUPN) United States $1.962B 26.71
Taysha Gene Therapies (TSHA) United States $0.434B 30.29
Personalis (PSNL) United States $0.261B 0.00
Assembly Biosciences (ASMB) United States $0.098B 0.00
Sol-Gel Technologies (SLGL) Israel $0.012B 0.00
Evoke Pharma (EVOK) United States $0.007B 0.00
Teligent (TLGT) United States $0.000B 0.00